The pressor response to sympathetic nerve stimulation in pulmonary blood vessels is mediated by alpha receptor activation from endogenous norepinephrine release.
Answers are grounded in this paper and cite their sources.
Supports mechanistic studies of pulmonary sympathetic control in animals; leaves open translation to human pulmonary vascular disease.
The effects of specific adrenergic blocking agents on pulmonary vascular responses to sympathetic nerve stimulation and norepinephrine were evaluated in the perfused dog lung using a new right heart catheterization procedure which avoids dissection and cannulation of lobar vessels. The increase in pulmonary vascular resistance in response to nerve stimulation and norepinephrine but not serotonin was antagonized by phentolamine, an alpha receptor blocking agent. Responses to nerve stimulation but not exogenous norepinephrine were antagonized by bretylium, an adrenergic nerve terminal blocking agent. It is concluded that the pressor response to nerve stimulation is due to activation of alpha receptors by endogenous norepinephrine released from sympathetic nerve endings in the pulmonary blood vessels.
No takes yet. Share an insight, caveat, or question.
Kadowitz et al. (1973) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: